Epinastine
Back to searchMolecule Structure
Scientific Name
Epinastine
Description of the Drug
Epinastine is an H1 receptor antagonist used to prevent itching in allergic conjunctivitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00751
http://www.drugbank.ca/drugs/DB00751
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Akorn Operating Co Llc, Sun Pharmaceutical Industries Ltd, Chartwell Rx Sciences Llc, Allergan Inc, Somerset Therapeutics Llc, Breckenridge Pharmaceutical Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL18794 | ||
PharmGKB | PA164764489 | ||
Human Metabolome Database | HMDB0014889 | ||
DrugBank | DB00751 | ||
PubChem: Thomson Pharma | 14847686 | ||
PubChem | 3241 | ||
LINCS | LSM-45639 | ||
Nikkaji | J22.791I | ||
BindingDB | 50131441 | ||
EPA CompTox Dashboard | DTXSID2048371 | ||
DrugCentral | 1027 | ||
ChemicalBook | CB2230197 | ||
Guide to Pharmacology | 7176 | ||
rxnorm | ELESTAT | EPINASTINE HYDROCHLORIDE | EPINASTINE |
ChEBI | 51032 |